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Abstract We showed in human melanoma cells tryptophan
hydroxylase (TPH) and hydroxyindole methyltransferase genes
expression with the sequential enzymatic activities of TPH,
serotonin (Ser) N-acetyltransferase and hydroxyindole methyl-
transferase. The presence of the products Ser, 5OH-tryptophan,
N-acetylserotonin, melatonin (Mel), 5-methoxytryptamine and
5-methoxytryptophol was documented by liquid chromatogra-
phy^mass spectrometry. Thus, human melanoma cells can
synthesize and metabolize Ser and Mel. ß 2002 Published by
Elsevier Science B.V. on behalf of the Federation of European
Biochemical Societies.
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1. Introduction
The neurotransmitter serotonin (Ser) is produced through a
multistep metabolic pathway starting with the hydroxylation
of L-tryptophan (Trp) by tryptophan hydroxylase (TPH: EC
1.14.16.4) to hydroxytryptophan, followed by decarboxylation
by an aromatic L-amino acid decarboxylase (EC 4.1.1.28) to
Ser [1,2]. In the brain, pineal gland and retina Ser is acetylated
by arylalkylamine N-acetyltransferase (AANAT: EC 2.3.1.87)
to N-acetylserotonin (NAS), which is further methylated by
hydroxyindole-O-methyltransferase (HIOMT: EC 2.1.1.4) to
produce melatonin (Mel) [3].
Melanocytes are cells of neural crest origin that, whether
normal or malignant, share the expression of a characteristic
metabolic pathway, melanogenesis, which involves production
of melanin. This is the result of a complex, multistep process
that starts with the hydroxylation of L-tyrosine [4]. Mel has
signi¢cant actions on melanocyte function, since it can inhibit
melanogenesis (at pharmacologic concentrations) or melano-
ma proliferation (at physiologic concentrations) (reviewed in
[5]). The Mel precursor, Ser, has been detected in malignant
and normal human melanocytes (reviewed in [5]), and we
reported that hamster skin can metabolize Ser to NAS and
possibly to Mel [6,7]. In the present investigation, we have
determined the full expression of the melatoninergic system
in melanoma cells.
2. Materials and methods
2.1. Chemicals
All reagents used for enzymatic assays and for high-performance
liquid chromatography (HPLC) separations were of the highest pu-
rity. L-[5-3H]Trp was from Amersham Life Sciences Inc. (Arlington
Heights, IL, USA). L-Trp, 5-OH L-Trp (5-OHTrp), Ser, NAS, Mel, 5-
methoxytryptamine (5MTT), 5-methoxytryptophol (5MTOL), N-ace-
tyltryptamine and tryptamine were purchased from Sigma (St. Louis,
MO, USA). All chemicals for biochemical assays not listed above,
including dye reagents for protein assay, were purchased from Sigma
(St. Louis, MO, USA).
2.2. Cell culture
SKMEL188 human melanoma cells were grown in Ham’s F10 me-
dium supplemented with 10% fetal bovine serum and antibiotics (Gib-
co-BRL, Gaithersburg, MD, USA) as described previously [8]. Under
the above conditions the cells maintain amelanotic phenotype [8].
Melanoma cells were detached using Ca and Mg free Tyrode’s solu-
tion containing 1 mM EDTA and used for biochemical or molecular
assays.
2.3. Reverse transcription-PCR (RT-PCR)
Total RNA was extracted from melanoma cells using Trizol isola-
tion kit (Gibco-BRL). The synthesis of ¢rst-strand cDNA was per-
formed using the Superscript preampli¢cation system (Gibco-BRL).
5 Wg of total RNA per reaction was reverse-transcribed according to the
manufacturer’s protocol using oligo(dT) as the primer. All samples
were standardized by the ampli¢cation of housekeeping gene GAPDH
as described previously by Robbins and Mc Kinney [9]. Primers were
synthesized by Integrated DNA Technology Inc. (Coralville, IA,
USA).
PCR ampli¢cations were performed under standard conditions with
modi¢cations where indicated. The reaction mixture (25 Wl) contained
2.5 mM MgCl2, 2.5 mM of each dNTP, 0.4 WM of each primer, 75
mM Tris^HCl (pH 8.8), 20 mM (NH4)2SO4, 0.01% Tween 20 and
0.25 U of Taq polymerase (Promega, Madison, WI, USA). The mix-
ture was heated to 94‡C for 2.5 min and then ampli¢ed for 35 or 30
cycles as speci¢ed, cycles were as follows: 94‡C for 30 s (denatura-
tion), 65‡C for 45 s (annealing) and 72‡C for 1 min (extension).
Ampli¢cation of human TPH cDNA. Primers P100 and P101 were
used in the ¢rst round of ampli¢cation. Sequences of primers were as
follows: P100 5P-AGCCAGATACCTGCCATGAAC-3P ; P101 5P-
GCTGCAGCTCATTCATGGCAC-3P. An aliquot of PCR mixture
from the ¢rst round of ampli¢cation was transferred to a new tube
and a second round of PCR was conducted. Primers for the second
round of PCR were: P106 5P-CCAAGAAATTGGCTTGGCTTCTC-
3P ; P107 5P-TGCTCTTGGTGTCTTTCAGGATC-3P.
Primers for the ¢rst round of human HIOMT gene ampli¢cation
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were: P118 (5P-TGAGAGAAGGAAGGAACCAGTAC-3P) and P119
(5P-CAAGTGTGGTAGATCCTCTCCAG-3P) ; and for the second
round: P120 (5P-GAAGAGCTTTTTACGGCCATCTAC-3P) and
P121 (5P-CGGAAGAGGGTCTTTGAAGAAATC-3P).
Identi¢ed PCR products were excised from the agarose gel and
puri¢ed by GFX PCR DNA and gel band puri¢cation kit (Amer-
sham-Pharmacia-Biotech). Sequencing was performed in the Molecu-
lar Resource Center at the University of Tennessee HSC (Memphis,
TN, USA) using an Applied Biosystems 3100 Genetic Analyzer and
BigDye1 Terminator kit.
2.4. Enzymatic assays
The radiometric assay for TPH was performed by Dr. Wilfred
Pinto, according to the methodology described by Beevers et al. [10]
with minor modi¢cations. Melanoma cells or rat brain were homog-
enized in ice-cold 50 mM Tris^HCl bu¡er (pH 7.6) containing 2 mM
dithiothreitol (DTT) in order to maintain the enzyme in the active
conformation. The crude cell homogenate was utilized as the source
material for the TPH assays. The assay mixture was composed of 50
mM Tris bu¡er containing 2 mM DTT, 100 WM L-Trp,V10 nM L-[5-
3H]Trp as radioactive tracer (V100 000 cpm, 31 Ci/mmol), 0.5 mM 6-
methyl-5,6,7,8-tetrahydropterine and crude cell homogenate contain-
ing 30^50 Wg protein in a ¢nal volume of 200 Wl. Adding the crude cell
homogenate to the prepared assay mixture started the reaction. In
control (background tubes) the cell extracts were substituted with
an equivalent volume of assay bu¡er. Following incubation for 120
min at 37‡C, the reactions were stopped by adding 40 Wl of 60%
perchloric acid (HClO4) to the assay mixture to the concentration
of 12%, and incubating for an additional 30 min at 37‡C. Assay
mixtures were then mixed with 250 Wl of a Norit-Dextran T70 slurry
(50 mg each/ml H20); the samples were vortexed and centrifuged and
the supernatants were used for liquid scintillation spectrometry in a
Beckman LS7000 spectrometer.
AANAT activity was measured by a modi¢cation of the method
described by Thomas et al. [11]. Cells were homogenized in an ice-cold
0.25 M potassium phosphate bu¡er (pH 6.8) containing 1 mM DTT,
1 mM EGTA, protease inhibitor cocktail (2 Wl/ml homogenization
mixture) and 0.625 mM acetyl coenzyme A (CoA). Homogenates
were centrifuged at 15 000Ug for 10 min at 4‡C. To measure enzy-
matic activity aliquots of 80 Wl of supernatant were mixed with 20 Wl
of 5 mM Ser or tryptamine in 0.25 M potassium phosphate bu¡er (pH
6.8). The ¢nal concentrations of acetyl CoA and amine substrate were
0.5 mM and 1 mM, respectively. The mixtures were then incubated
for 1 h at 37‡C, and the enzymatic reaction was stopped by the
addition of 20 Wl of 6 M HClO4. After centrifugation in a micro-
centrifuge at 4‡C, the supernatant (30^35 Wl) was subjected to
HPLC in a system equipped with a Novapak C18 reverse-phase col-
umn (100U5 mm, i.d.) and £uorometric detector (Waters). The de-
tector was calibrated with excitation and emission wavelengths set at
285 and 360 nm, respectively. The elution was carried out isocratically
at ambient temperature with a £ow rate of 1.5 ml/min for the di¡erent
mobile phases depending upon the amine substrate used. The mobile
phase contained 4 mM sodium 1-octanesulfonate as ion-pairing agent,
50 mM ammonium formate (pH 4.0) versus methanol (80:20) for Ser
and (75:25) for tryptamine. Elution peaks of NAS and N-acetyltrypt-
amine were identi¢ed by retention time (RT). Their identity was veri-
¢ed by their co-eluting with authentic standards. Quantitation was
based upon calibration curves constructed from directly injected stan-
dard compounds (NAS and N-acetyltryptamine) and the concentra-
tion of the test samples was determined by interpolation. For back-
ground controls, the reaction mixture was incubated either without
substrates or without an enzyme source.
HIOMT activity was assayed by a modi¢cation of the method
described in [12], which is based on HPLC separation and £uoromet-
ric detection of Mel formed enzymatically from NAS and S-adenosyl-
L-methionine. Brie£y, melanoma cells were homogenized in an ice-
cold 0.05 M sodium phosphate bu¡er (pH 7.9) containing 0.625
mM S-adenosyl-L-methionine. Homogenates were centrifuged at
15 000Ug for 10 min at 4‡C. Aliquots of 80 Wl of supernatant were
mixed with 20 Wl of 5 mM NAS in 0.05 M sodium phosphate bu¡er
(pH 7.9). The ¢nal concentrations of S-adenosyl-L-methionine and
NAS were 0.5 mM and 1 mM, respectively. The mixtures were then
incubated for 1 h at 37‡C, and the enzymatic reaction was stopped by
adding 20 Wl of 6 M HClO4. After centrifugation in a microcentrifuge
at 4‡C, the supernatant (60 Wl) was subjected to HPLC analysis in the
system described above for the measurement of AANAT activity with
tryptamine as substrate. Elution peaks of NAS and Mel were identi-
¢ed by RT. Their identity was veri¢ed by their co-eluting with au-
thentic standards and quantitation was conducted as described above.
For background controls, the reaction mixture was incubated either
without substrate or without an enzyme source. Protein concentration
was determined by a dye-binding method with bovine serum albumin
(BSA) as the standard [8].
2.5. Immunohistochemistry
Melanoma cells grown on glass coverslips were ¢xed in 4% bu¡ered
paraformaldehyde, washed with 50 mM Tris^HCl bu¡er (pH 7.6) and
then incubated for 10 min in 30% v/v methanol:Tris bu¡er containing
20 Wl of 30% H2O2 to block endogenous peroxidase. The non-speci¢c
binding was blocked by incubation for 1 h in Tris bu¡er containing
10% normal goat serum. The coverslips were then incubated for 18 h
at room temperature with anti-Ser (Diasorin Corp., Stillwater, MN,
USA) and anti-TPH sera (Chemicon, Temecula, CA, USA) diluted
1:5000 and 1:1000, respectively, with Tris bu¡er containing 1% BSA
and 0.25% Triton X-100. After washing the coverslips were incubated
with biotin-conjugated goat anti-rabbit polyclonal antibody (Vector
Laboratories, Burlingame, CA, USA), and the presence of the
primary antibody^secondary antibody complex was revealed by the
avidin^biotin peroxidase complex method (Vector Elite kit, Vector
Laboratories). The immune complexes were visualized using diamino-
benzidine tetrahydrochloride as the chromogen.
2.6. Liquid chromatography^mass spectrometry (LC/MS)
The melanoma samples were analyzed by LC/MS using a Agilent
1100 Series LC/MSD SL mass spectrometer with atmospheric pressure
interface^electrospray (API^ES) interface and with Agilent 1100 Se-
ries HPLC system with a high pressure binary pump (Agilent Tech-
nologies Inc., Wilmington, DE, USA), in the tandem mode. Brie£y,
SKMEL188 melanoma cell pellets were suspended in 0.1 N HCl,
sonicated, centrifuged for 10 min at 15 000Ug and supernatants
were ¢ltered through a Millex-LH ¢lter (0.45 Wm pore size). Aliquots
of 2 Wl were separated on a Agilent 1100 Series System through a
Zorbax Eclipse XDB-C18 column (1.0 mm IDU150 mm L, 3.5 Wm
particle) with a mobile phase A: water with 7% methanol and 0.1%
tri£uoroacetic acid (TFA), and mobile phase B: methanol with 0.1%
TFA. Separation was performed with methanol at the following gra-
dients: 7% (1^12 min), 23% (12^15 min), 35% (15^20.1 min) and 7%
(20.1^26 min), while maintaining the £ow rate at 0.08 ml/min. The
e¥uent from the HPLC system was routed to the MS through API^
ES with selective ion monitoring (SIM) for m/z 177 (0^5.5 min), 221
(5.5^7 min), 217 (7^15 min), 205 (15^16.5 min), 191 (16.5^19 min) and
192 (19^23 min). The spray chamber conditions were as follows: gas
temperature: 300‡C; drying gas: 9 l/min; nebulizer pressure: 40 psig;
VCap (positive): 3500 V. The corresponding standards were similarly
analyzed by LC/MS under the same conditions.
3. Results
3.1. Enzymatic activities
Direct biochemical assays for enzymatic conversion of Trp
to hydroxytryptophan showed high activity in SKMEL188
melanoma cells, comparable to that in the rat brain. The
respective TPH activities (nmol of Trp hydroxylated/mg pro-
tein/h) were 3.03 þ 0.47 (n = 3) and 2.39 þ 0.12 (n = 6) for rat
brain and human melanoma homogenates, respectively.
Using reverse-phase HPLC (RP-HPLC) with £uorimetric
detection we conclusively established the presence of AANAT
and HIOMT activities in melanoma cells (Figs. 1 and 2).
Thus, after the addition of acetyl CoA, cell extracts trans-
formed Ser to NAS and tryptamine to N-acetyltryptamine.
In addition, melanoma extracts subjected to RP-HPLC
showed £uorescence at the RTs of Ser standard, indicating
intracellular (endogenous) production of this amine. Fig. 2
shows transformation of NAS to Mel.
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3.2. TPH and HIOMT genes expression
Using human-speci¢c primers located at exons 7 and 10 for
TPH and exons 4 and 8 for HIOMT we performed RT-PCR
on RNA from melanoma cells and detected species of 380 bp
for TPH and a 171 bp fragment of HIOMT (Fig. 3). The
ampli¢ed fragments were sequenced and showed 100% nucle-
otide sequence homology with the corresponding genes. The
PCR fragment of HIOMT corresponded to mRNA lacking
exons 6 and 7. This isoform was previously detected by Ro-
driguez et al. [13] who demonstrated that HIOMT mRNA is
produced and alternatively spliced in the pineal gland and also
in retina. However, the activity of this HIOMT isoform is still
unresolved. The sixth exon of the human HIOMT gene cor-
responds to the line-1 repetitive element, and this sequence is
not found in chicken or cow HIOMT genes. Thus it is as-
sumed that this exon is a recent evolutionary development and
is not critical for HIOMT activity [13].
The immunocytochemistry was consistent with gene studies
showing in melanoma cells the presence of TPH immunore-
activity and Ser-like immunoreactivity in melanoma cells (not
shown).
3.3. LC/MS analysis
Extract ion chromatography analysis at speci¢c masses
Fig. 1. HPLC chromatogram obtained from reaction mixture in which melanoma cells were the enzyme source: experimental incubation with
acetyl CoA and Ser (A) or tryptamine (C) and corresponding control extracts without amine substrate (B and D). The numbers indicate the
elution positions of standards. 1 ^ NAS (A and B) or N-acetyltryptamine (C); 2 ^ Ser (A and B) or tryptamine (C).
Fig. 2. HPLC chromatogram showing transformation of NAS to Mel in melanoma cell extracts. Experimental incubation with NAS (A) and
corresponding control incubation without NAS (B). The numbers indicate the elution positions of standards: 1 ^ Mel or 2 ^ NAS.
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showed adduct ions (M+H) at m/z 205 with RT 16 min; 191
with RT 17. 1; 192 with RT 22.6; and 233 with RT 23.5 that
were identi¢ed as Trp, 5MTT, 5MTOL and Mel, because they
corresponded to the (M+H) of the respective standards with
almost identical RT (calculated masses were 204, 190, 191 and
232 Da, respectively) (Fig. 4). The appearance of minor peaks
with RT 4.7, 6.4 and 13.3 min at m/z 177, 221 and 219,
respectively, indicated the presence of Ser, 5-OHTrp and
NAS (calculated masses were 176, 220 and 218 Da). The
structure of the adduct ions (M+H) at m/z 221 with RT
7.7 min and 219 with RT 5.6 and 7.7 min and 219 with RT
9 min is unknown.
4. Discussion
We are providing here the ¢rst evidence for the existence of
a novel melatoninergic system expressed in melanoma cells.
This is documented by expression of the TPH gene and its
enzymatic activity, detection of AANAT and HIOMT activ-
ities with expression of the HIOMT gene. The actual detection
of Ser, 5-OHTrp, NAS and Mel in extracts of melanoma cells
by LC/MS demonstrates that this melatoninergic system is
operating in cultured cells in vitro. Identi¢cation of 5MTT
and 5MTOL indicates metabolism of Mel to these com-
pounds, following a pathway similar to that described in ret-
ina and in frog skin [14].
Ser has multiple functions acting as neurotransmitter, reg-
ulator of vascular tone, immunomodulator and as growth
factor [2,15]. In the skin, some of the local activities of Ser
include those of being pro-edema, vasodilatory, proin£amma-
tory and/or pruritogenic agent [5]. Mel, in turn, can also act
as a hormone, neurotransmitter, cytokine, biological modi¢er
and immunomodulator [3]. Thus, the uncovering of endoge-
nous Ser synthesis and its transformation to Mel underlines a
putative important role of this pathway in melanocyte phys-
iology and pathology.
One possible melanocytic role for endogenous Mel could be
as an intracrine regulator of melanogenesis, or as a scavenger
of free radicals produced during melanogenesis, since Mel and
related compounds can act as free radical scavengers [16].
Furthermore, in at least some rodent melanomas, Mel has
been shown to inhibit melanogenesis (reviewed in [5]). Anoth-
er possible role for the currently reported serotonergic and
melatoninergic systems could be modi¢cation of tumor micro-
environment by intermediates of the pathway acting in auto-
or paracrine fashions. Thus, the present ¢ndings uncover a
range of new possibilities in pigment and melanoma biology
that can be tested in further studies on the role of endoge-
nously produced Ser, Mel and their metabolites.
In conclusion, we provide the ¢rst evidence for the expres-
sion of novel Ser and Mel biosynthetic pathways in melanoma
cells, together with documentation of their possible local deg-
radation.
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